Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Author

Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Chief Executive Officer

Display #

Title	Created Date	Category
FDA Confirms That Use of mFARS as Primary Endpoint in Part 2 of the MOXIe Trial Can Support Approval of Omaveloxolone in Friedreich’s Ataxia	Monday, August 14, 2017	Scientific News
Heart and Nervous System Pathology in Compound Heterozygous Friedreich Ataxia	Thursday, August 10, 2017	Funded Research
Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia	Tuesday, August 8, 2017	Scientific News
Chondrial Announces FDA Orphan Drug Designation for CTI-1601, a Novel Investigational Technology for the Treatment of Friedreich's Ataxia	Thursday, August 3, 2017	Scientific News
Pharmacological therapeutics in Friedreich Ataxia: The present state	Friday, July 21, 2017	Funded Research
Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model	Friday, July 21, 2017	Funded Research
Call for Abstracts - 10th Annual Friedreich’s Ataxia Symposium	Thursday, July 20, 2017	Scientific News
AFAF and FARA invite proposals for research projects that advance drug discovery, development of novel biomarkers or improve clinical outcomes in Friedreich’s ataxia patients	Sunday, July 16, 2017	Funded Research
Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients	Friday, July 14, 2017	Scientific News
How does performance of the Friedreich Ataxia Functional Composite compare to rating scales?	Wednesday, July 12, 2017	Funded Research

Page 9 of 78

Start
Prev
4
5
6
7
8
9
10
11
12
13
Next
End

Site Map Privacy Policy Service Terms Contact

Charity Navigator